Sort by
Neuroscience
Alzheimer's Disease
100%
Positron Emission Tomography
52%
Positron Emission Tomography
50%
Mild Cognitive Impairment
44%
Fluorine-18
41%
Amyloid
33%
2-Deoxy-D-Glucose
27%
Pharmacokinetics
24%
Dementia with Lewy Bodies
22%
Gray Matter
22%
Neurodegenerative Disorder
15%
Behavior Disorder
13%
Rapid Eye Movement Sleep
13%
Parkinson's Disease
13%
Image Processing
11%
Parietal Cortex
9%
Cognitive Disorders
8%
Differential Diagnosis
8%
Functional Magnetic Resonance Imaging
7%
Synuclein
6%
Brain Metabolism
6%
Cerebellum
6%
Brainstem
5%
Inositol
5%
Statistical Parametric Mapping
5%
Single-Photon Emission Computed Tomography
5%
Tauopathy
5%
Neutrophil Gelatinase Associated Lipocalin
5%
Dopamine Transporter
5%
Choline
5%
Olfaction
5%
Molecular Imaging
5%
Depression
5%
Frontal Lobe
5%
Temporal Lobe
5%
Keyphrases
Alzheimer's Disease
16%
Mild Cognitive Impairment
12%
Regional Cerebral Blood Flow (rCBF)
10%
Frontotemporal Dementia
8%
Neurodegenerative Diseases
7%
Pittsburgh Compound B PET
7%
Flow Image
7%
Cerebral Blood Flow
7%
Amnestic Mild Cognitive Impairment (aMCI)
7%
Pittsburgh Compound B
6%
Depressive Symptoms
5%
Dopamine Transporter SPECT
5%
Pharmacokinetic Modeling
5%
Older Adults
5%
B-scan
5%
SUVr
5%
Diagnostic Performance
5%
Emotion Recognition
5%
18F-fluoro-2-deoxy-D-glucose
5%
Single-subject Studies
5%
Principal Coordinate Analysis (PCoA)
5%
Parametric PET Images
5%
Alzheimer's Dementia
5%
Subprofiles
5%
Disease Pattern
5%
Parameter Estimation
5%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
5%
Risk-taking Behavior
5%
Amnestic MCI
5%
Self-neglect
5%
Cognitive Performance
5%
PET Scan
5%
Metabolic Pattern
5%
Temporal Dynamics
5%
PiB-PET
5%
Interregional Correlation
5%
Traffic-related
5%
Metabolic Connectivity
5%
Older Persons
5%
Dynamic Model
5%
Cognitive Impairment
5%
Native Spaces
5%
Image Processing Methodology
5%
MR Image Processing
5%
Cerebrospinal Fluid
5%
Nuclear Imaging
5%
Gray Matter
5%
Source-based Morphometry
5%
Structural Network
5%
Cognitive Correlates
5%
Medicine and Dentistry
Alzheimer's Disease
40%
Fluorodeoxyglucose F 18
23%
Positron Emission Tomography
20%
Biological Marker
16%
Carbon 11
15%
Cerebrospinal Fluid
12%
B Scan
11%
Pittsburgh Compound B
11%
Positron Emission Tomography
11%
Mild Cognitive Impairment
10%
Radioactive Tracer
9%
Parietal Cortex
8%
Tau
8%
Differential Diagnosis
7%
Diagnostic Performance
6%
Brain Blood Flow
6%
Parkinson's Disease
6%
Multivariate Analysis
6%
Diaschisis
6%
Inositol
5%
Univariate Analysis
5%
Randomized Controlled Trial
5%
Standardized Uptake Value
5%
Middle Age
5%
Risk Reduction
5%
Self Neglect
5%
Synucleinopathies
5%
Choline
5%
Fluorodeoxyglucose
5%
Molecular Imaging
5%
Polyethylene Terephthalate
5%
Diagnosis
5%
